ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Identification of PAFAH1B3 as Candidate Prognosis Marker and Potential Therapeutic Target for Hepatocellular Carcinoma

Xu, Weikang; Lu, Xinyu; Liu, Jing; Chen, Qianhui; Huang, Xuan; Huang, Kuiyuan; Liu, Hongyan*; Zhu, Wei*; Zhang, Xiaoyong*南方医科大学; 中山大学
Frontiers in Oncology2021-8-19DOI: 10.3389/fonc.2021.700700
4被引13阅读
引用收藏
分享

摘要

Background Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related deaths worldwide. PAFAH1B3 plays an important role on occurrence and development in a variety tumor. However, the function of PAFAH1B3 in HCC remains unclear. Methods The TIMER, ONCOMINE, Human Protein Atlas (HPA), GEPIA, The Cancer Genome Atlas (TCGA), HCCDB, UALCAN and LinkedOmics database were used to analyze the prognostic value, co-expression genes and regulator networks of PAFAH1B3 in HCC. siRNA transfections and inhibitor of PAFAH1B3 P11 were used to verify the anti-tumor effect on HCC cell lines. Gene expression was detected by qRT-PCR. The functions of PAFAH1B3 downregulation in HCC cell lines were investigated using cell cycle analysis, apoptosis detection, CCK8 assay and transwell assay. Western blot was used to evaluate the role of PAFAH1B3 on metabolic pathways in HCC cells. Results Based on the data from databases, the expression of PAFAH1B3 was remarkably increased in HCC patients. High expression of PAFAH1B3 was associated with poorer overall survival (OS) and disease-free survival (DFS). And PAFAH1B3 was notably linked to age, sex, grade, stage, race, and TP53 mutational status. Then, the functional network analysis showed PAFAH1B3 may be involved in HCC through cell cycle, cell metabolism, spliceosome, and RNA transport. Furthermore, the mRNA expression of PAFAH1B3 was also increased in HCC cell lines. Flow cytometry analysis showed that PAFAH1B3 manipulated apoptosis and cell cycle regulation. CCK8 assay showed that PAFAH1B3 silencing or pharmacologic inhibitor of PAFAH1B3 inhibited the proliferation of HepG2, Huh7 and MHCC-97H cells. Transwell assay results showed that PAFAH1B3 silencing also significantly impaired the invasion and migratory ability of HCC cells. In addition, PAFAH1B3 silencing significantly downregulated the expression of glycolysis and lipid synthesis signaling pathways. Conclusion Our findings suggested that PAFAH1B3 plays a critical role in progression of HCC. PAFAH1B3 as a prognosis marker and potential target for HCC has prospective clinical significance.

学科与关键词

关键词
hepatocellular carcinomabiomarkerprognosiscancer databases
相关
加载中…
  • PAK3 promotes the metastasis of hepatocellular carcinoma by regulating EMT process
    Gao, Zhi; Zhong, Mengya; Ye, Zhijian; Wu, Zhengxin; Xiong, Yubo; Ma, Jinsong; Chen, Huiyu; Zhu, Yuekun; Yang, Yan; Zhao, Yongxiang*; Zhang, Zhiyong*American Journal of Cancer Research, 2022, 13(1): 153-161.被引 8
  • Cleavage and polyadenylation-specific factor 3 induces cell cycle arrest via PI3K/Akt/GSK-3β signaling pathways and predicts a negative prognosis in hepatocellular carcinoma
    Li, Ning; Jiang, Shaotao; Fu, Rongdang; Lv, Jin; Yao, Jiyou; Mai, Jialuo; Hua, Xuefeng; Chen, Huan; Liu, Jie; Lu, Minqiang*Biomarkers in Medicine, 2021, 15(5): 347-358.被引 5
  • Upregulation of SKA3 enhances cell proliferation and correlates with poor prognosis in hepatocellular carcinoma
    Tang, Jianxin; Liu, Jing; Li, Jinjun; Liang, Ziming; Zeng, Kaining; Li, Haibo; Zhao, Zhenlin; Zhou, Li*; Jiang, Nan*Oncology Reports, 2021, 45(4): 48.被引 5
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2021-08-19
卷期
第 11 卷
DOI
10.3389/fonc.2021.700700
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81802449, 81871664]

作者

  • X

    Xu, Weikang (第一作者)

    southern med univ

  • L

    Lu, Xinyu

    southern med univ

查看全部 9 位作者收起作者
  • L

    Liu, Jing

    sun yat sen univ

  • C

    Chen, Qianhui

    southern med univ

  • H

    Huang, Xuan

    southern med univ

  • H

    Huang, Kuiyuan

    southern med univ

  • L

    Liu, Hongyan (通讯)

    southern med univ

  • Z

    Zhu, Wei (通讯)

    southern med univ

  • Z

    Zhang, Xiaoyong (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417